EP2276485
Notkun á epóþílón D við meðferð á Tau-tengdum sjúkdómum, þar á meðal Alzheimers-sjúkdómi
:
EP Einkaleyfi fallið úr gildi:
24.4.2009:
16.7.2014:
09735906.1
:
18.8.2014:
15.9.2014
:
23.4.2029:
23.4.2017
:
USE OF EPOTHILONE D IN TREATING TAU-ASSOCIATED DISEASES INCLUDING ALZHEIMER'S DISEASE
24.4.2009
16.7.2014
18.8.2014
15.9.2014
23.4.2017
:
Bristol-Myers Squibb Company:
Route 206 and Province Line Road P.O. Box 4000, 08543-4000, Princeton, US
:
ALBRIGHT, Charles, F.:
Wallingford, Connecticut, US
:
BARTEN, Donna, Marie:
Wallingford, Connecticut, US
:
LEE, Francis, Y.:
New, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
47729:
24.4.2008:
US
:
WO2009132253:
24.4.2009
:
A61K 31/427, A61P 25/00, A61P 25/16, A61P 25/28, A61P 27/00
: 7
: 9.3.2015
: 23.4.2016
: Árnason Faktor
: 8
: 11.3.2016
: 23.4.2017
: Árnason Faktor